XERS - Xeris Biopharma Holdings, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.00
DETAILS
HIGH:
$9.00
LOW:
$9.00
MEDIAN:
$9.00
CONSENSUS:
$9.00
UPSIDE:
45.40%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 291.8 | 203.1 | 163.9 | 110.2 | 49.6 | 20.4 | 2.7 | 2.5 | 1.6 | 1.1 |
| Cost of Revenue | 53.4 | 36.8 | 28.6 | 22.6 | 13.3 | 9.3 | 1.6 | 0.0 | 0.0 | 0.0 |
| Gross Profit | 238.4 | 166.2 | 135.3 | 87.6 | 36.3 | 11.1 | 1.1 | 2.4 | 1.6 | 1.1 |
| Operating Expenses | ||||||||||
| R&D Expenses | 31.2 | 25.6 | 22.3 | 21.0 | 25.2 | 20.9 | 60.4 | 40.7 | 20.2 | 10.2 |
| SG&A Expenses | 182.4 | 163.5 | 146.1 | 137.7 | 125.7 | 73.7 | 63.1 | 21.1 | 8.0 | 4.1 |
| Other Expenses | 0 | 10.8 | 10.8 | 10.8 | 0.6 | 0 | 0 | 0 | (0.0) | (0.0) |
| Operating Expenses | 213.5 | 199.9 | 179.3 | 169.6 | 151.4 | 94.7 | 123.5 | 61.8 | 28.2 | 14.3 |
| Operating Income | ||||||||||
| Operating Income | 24.9 | (33.6) | (44.0) | (81.9) | (115.2) | (83.5) | (122.4) | (59.3) | (26.6) | (13.2) |
| Interest Expense | 29.1 | 33.2 | 26.6 | 14.1 | 7.2 | 7.4 | 7.2 | 2.5 | 0.0 | 0.0 |
| Interest Income | 4.7 | 5.3 | 4.8 | 2.6 | 0.3 | 4.5 | 2.8 | 1.6 | 0.1 | 0.0 |
| Profitability | ||||||||||
| EBITDA | 12.7 | (14.0) | (23.7) | (69.3) | (113.7) | (79.1) | (117.8) | (57.2) | (26.4) | (13.1) |
| EBIT | 0.6 | (26.6) | (36.9) | (82.0) | (115.5) | (80.6) | (118.9) | (57.5) | (26.6) | (13.2) |
| Income Before Tax | 0.6 | (57.1) | (63.5) | (96.1) | (122.7) | (91.2) | (126.0) | (60.1) | (26.6) | (13.2) |
| Income Tax Expense | 0 | (2.3) | (1.2) | (1.4) | 0 | (0.1) | (0.5) | 0 | 0.0 | (0.0) |
| Net Income | 0.6 | (54.8) | (62.3) | (94.7) | (122.7) | (91.1) | (125.6) | (60.1) | (26.6) | (13.2) |
| Per Share Data | ||||||||||
| EPS (Basic) | 0.00 | -0.37 | -0.45 | -0.70 | -1.55 | -2.14 | -3.49 | -4.99 | -13.09 | -7.17 |
| EPS (Diluted) | 0.00 | -0.37 | -0.45 | -0.70 | -1.55 | -2.14 | -3.49 | -4.99 | -13.09 | -7.17 |
| Shares Outstanding | 160.4 | 146.8 | 137.7 | 135.6 | 79.0 | 42.6 | 26.1 | 12.0 | 2.0 | 1.8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 111.0 | 71.6 | 67.4 | 122.0 | 67.3 | 37.6 | 19.5 | 45.7 | 42.0 | 32.3 |
| Short-Term Investments | 0 | 0 | 5.0 | 0 | 35.2 | 96.2 | 56.0 | 66.9 | 0 | 0 |
| Net Receivables | 51.0 | 40.4 | 39.2 | 30.8 | 17.5 | 6.9 | 4.7 | 2.9 | 1.2 | 0.1 |
| Inventory | 68.7 | 48.2 | 38.8 | 24.7 | 18.1 | 8.4 | 2.2 | 0 | 0 | 0 |
| Other Current Assets | 9.5 | 7.5 | 5.8 | 9.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 240.3 | 167.7 | 156.3 | 186.8 | 142.6 | 152.2 | 87.5 | 117.9 | 44.1 | 33.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 27.1 | 28.2 | 29.2 | 9.5 | 6.6 | 6.7 | 7.9 | 2.0 | 0.8 | 0.3 |
| Goodwill | 22.9 | 22.9 | 22.9 | 22.9 | 22.9 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 88.1 | 98.9 | 109.8 | 120.6 | 131.4 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 4.1 | 0 | 0 | 0 | 0 | 13.2 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.2 | (4.8) | 4.5 | 4.7 | 0.8 | 0.2 | 0.4 | 0.1 | 0.2 | 0.0 |
| Total Non-Current Assets | 143.2 | 155.4 | 166.3 | 157.7 | 161.8 | 6.9 | 21.5 | 2.1 | 0.9 | 0.4 |
| Total Assets | 383.5 | 323.1 | 322.6 | 344.5 | 304.4 | 159.2 | 109.0 | 120.0 | 45.0 | 33.5 |
| Current Liabilities | ||||||||||
| Account Payables | 3.1 | 2.3 | 11.6 | 4.6 | 8.9 | 3.1 | 5.6 | 0.9 | 2.0 | 1.3 |
| Short-Term Debt | 6.2 | 15.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.2 | 0.3 |
| Other Current Liabilities | 100.3 | 39.7 | 51.4 | 27.2 | 25.6 | 11.2 | 9.1 | 5.0 | 1.3 | 0.5 |
| Total Current Liabilities | 109.6 | 100.4 | 95.2 | 73.6 | 79.0 | 28.2 | 27.3 | 10.2 | 4.9 | 2.5 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 31.5 | 217.0 | 190.9 | 187.1 | 88.1 | 87.0 | 58.3 | 31.9 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 2.3 | 3.5 | 4.9 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 228.7 | 2.0 | 6.2 | 25.7 | 37.1 | 10.2 | 8.9 | 2.6 | 98.0 | 62.9 |
| Total Non-Current Liabilities | 260.3 | 252.2 | 234.2 | 225.7 | 130.1 | 97.2 | 67.2 | 34.5 | 98.0 | 62.9 |
| Total Liabilities | 369.8 | 352.7 | 329.4 | 299.3 | 209.1 | 125.4 | 94.6 | 44.6 | 102.8 | 65.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (671.3) | (671.9) | (617.0) | (554.8) | (460.1) | (337.4) | (246.2) | (120.7) | (60.6) | (34.0) |
| Accumulated Other Comprehensive Income | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | 0.0 | 0.0 | (0.1) | (0.4) | (0.3) |
| Total Stockholders' Equity | 13.7 | (29.6) | (6.8) | 45.2 | 95.2 | 33.8 | 14.4 | 75.4 | (57.8) | (31.9) |
| Total Liabilities & Equity | 383.5 | 323.1 | 322.6 | 344.5 | 304.4 | 159.2 | 109.0 | 120.0 | 45.0 | 33.5 |
| Debt Metrics | ||||||||||
| Total Debt | 37.8 | 271.4 | 229.2 | 198.1 | 88.1 | 87.0 | 58.3 | 31.9 | 0 | 0 |
| Net Debt | (73.3) | 199.8 | 161.7 | 76.1 | 20.8 | 49.4 | 38.8 | (13.8) | (42.0) | (32.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 0.6 | (54.8) | (62.3) | (94.7) | (122.7) | (91.1) | (91.1) | (60.1) | (26.6) | (13.2) |
| Depreciation & Amortization | 12.2 | 12.6 | 13.2 | 12.7 | 1.9 | 1.5 | 1.5 | 0.3 | 0.2 | 0.1 |
| Stock-Based Compensation | 22.4 | 18.4 | 10.7 | 12.2 | 11.4 | 8.3 | 6.5 | 1.7 | 0.5 | 0.5 |
| Change in Working Capital | (10.4) | (8.8) | (6.3) | (35.1) | 11.9 | (0.3) | (2.8) | 1.6 | 1.1 | (3.6) |
| Other Non-Cash Items | 3.9 | (2.0) | (1.1) | 3.5 | 3.5 | 0.0 | 4.9 | 0.6 | 0.1 | 0.0 |
| Operating Cash Flow | 28.6 | (37.0) | (47.0) | (102.9) | (102.9) | (95.5) | (80.6) | (56.3) | (24.7) | (16.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.7) | (0.9) | (2.3) | (0.5) | (0.5) | (1.1) | (0.4) | (1.5) | (0.7) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0 | 38.5 | 0 | 0.4 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (34.5) | (43.7) | 0 | (43.0) | (101.8) | (101.8) | (68.9) | 0 | 0 |
| Sales/Maturities of Investments | 0 | 40.2 | 40 | 35.0 | 35.0 | 74.7 | 74.7 | 2.1 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 4.6 | 0 | (0.4) | (66.8) | 0 | 0 |
| Investing Cash Flow | (0.7) | 4.9 | (6.0) | 34.5 | 34.5 | (27.4) | (27.4) | (68.3) | (0.7) | (0.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 9.2 | 38.2 | 0 | 102.7 | 0 | 69.8 | 25 | 35 | 0 | (0.0) |
| Stock Repurchased | (10.9) | (3.7) | (1.0) | (0.5) | (0.5) | (0.1) | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 1.7 | (0.6) | (4.8) | 0 | (9.5) | 101.1 | (0.3) | (0.3) | (0.1) |
| Financing Cash Flow | 11.4 | 36.2 | (1.6) | 127.5 | 27.2 | 126.1 | 126.1 | 128.2 | 35.1 | 3.9 |
| Cash Position | ||||||||||
| Net Change in Cash | 39.3 | 4.1 | (54.6) | 59.0 | 59.0 | 29.7 | 18.1 | 3.7 | 9.8 | (12.2) |
| Cash at Beginning | 75.7 | 71.7 | 126.3 | 67.3 | 67.3 | 37.6 | 19.5 | 42.0 | 32.3 | 44.5 |
| Cash at End | 115.1 | 75.7 | 71.7 | 126.3 | 126.3 | 67.3 | 37.6 | 45.7 | 42.0 | 32.3 |
| Free Cash Flow | 27.9 | (37.8) | (49.3) | (103.4) | (103.4) | (96.6) | (80.9) | (57.8) | (25.4) | (16.1) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 291.8 | 203.1 | 163.9 | 110.2 | 49.6 | 20.4 | 2.7 | 2.5 | 1.6 | 1.1 |
| Gross Profit | 238.4 | 166.2 | 135.3 | 87.6 | 36.3 | 11.1 | 1.1 | 2.4 | 1.6 | 1.1 |
| Operating Income | 24.9 | (33.6) | (44.0) | (81.9) | (115.2) | (83.5) | (122.4) | (59.3) | (26.6) | (13.2) |
| Net Income | 0.6 | (54.8) | (62.3) | (94.7) | (122.7) | (91.1) | (125.6) | (60.1) | (26.6) | (13.2) |
| EPS (Diluted) | 0.00 | -0.37 | -0.45 | -0.70 | -1.55 | -2.14 | -3.49 | -4.99 | -13.09 | -7.17 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 111.0 | 71.6 | 67.4 | 122.0 | 67.3 | 37.6 | 19.5 | 45.7 | 42.0 | 32.3 |
| Total Assets | 383.5 | 323.1 | 322.6 | 344.5 | 304.4 | 159.2 | 109.0 | 120.0 | 45.0 | 33.5 |
| Total Debt | 37.8 | 271.4 | 229.2 | 198.1 | 88.1 | 87.0 | 58.3 | 31.9 | 0 | 0 |
| Stockholders' Equity | 13.7 | (29.6) | (6.8) | 45.2 | 95.2 | 33.8 | 14.4 | 75.4 | (57.8) | (31.9) |
| Cash Flow | ||||||||||
| Operating Cash Flow | 28.6 | (37.0) | (47.0) | (102.9) | (102.9) | (95.5) | (80.6) | (56.3) | (24.7) | (16.1) |
| Capital Expenditure | (0.7) | (0.9) | (2.3) | (0.5) | (0.5) | (1.1) | (0.4) | (1.5) | (0.7) | (0.0) |
| Free Cash Flow | 27.9 | (37.8) | (49.3) | (103.4) | (103.4) | (96.6) | (80.9) | (57.8) | (25.4) | (16.1) |